21st Sep 2022 11:22 am |
RNS |
Director/PDMR Shareholding |
13th Sep 2022 9:11 am |
RNS |
Director/PDMR Shareholding |
9th Sep 2022 9:11 am |
RNS |
Publication of Base Prospectus |
8th Sep 2022 12:58 pm |
RNS |
Director/PDMR Shareholding |
6th Sep 2022 1:00 pm |
RNS |
GSK provides update on FDA review of daprodustat |
1st Sep 2022 11:48 am |
RNS |
Total Voting Rights |
24th Aug 2022 7:00 am |
RNS |
GSK Board changes |
22nd Aug 2022 4:53 pm |
RNS |
Director/PDMR Shareholding |
17th Aug 2022 7:00 am |
RNS |
FDA New Drug Application File Acceptance for MMB |
17th Aug 2022 7:00 am |
RNS |
Statement: Zantac (ranitidine) litigation update |
16th Aug 2022 7:06 am |
RNS |
GSK completes acquisition of Affinivax, Inc. |
12th Aug 2022 7:00 am |
RNS |
Statement: Zantac (ranitidine) litigation |
11th Aug 2022 11:51 am |
RNS |
Director/PDMR Shareholding |
10th Aug 2022 4:57 pm |
RNS |
Director/PDMR Shareholding |
1st Aug 2022 6:10 pm |
RNS |
Total Voting Rights |
1st Aug 2022 1:43 pm |
RNS |
Director/PDMR Shareholding |
29th Jul 2022 2:00 pm |
RNS |
Director/PDMR Shareholding |
29th Jul 2022 10:00 am |
RNS |
GSK Board change |
28th Jul 2022 1:01 pm |
RNS |
Director/PDMR Shareholding |
27th Jul 2022 7:00 am |
RNS |
2nd Quarter Results |
26th Jul 2022 5:35 pm |
RNS |
Holding(s) in Company |
22nd Jul 2022 4:45 pm |
RNS |
Holding(s) in Company |
22nd Jul 2022 4:17 pm |
RNS |
Board and Committee Changes |
19th Jul 2022 7:00 am |
RNS |
Completion of GSK Share Consolidation |
18th Jul 2022 6:00 pm |
RNS |
Holding(s) in Company |
18th Jul 2022 7:00 am |
RNS |
Haleon demerger completion and share consolidation |
12th Jul 2022 9:48 am |
RNS |
Director/PDMR Shareholding |
11th Jul 2022 5:30 pm |
RNS |
GSK |
8th Jul 2022 6:04 pm |
RNS |
Director/PDMR Shareholding |
8th Jul 2022 5:30 pm |
RNS |
Director/PDMR Shareholding |
8th Jul 2022 3:53 pm |
RNS |
Director/PDMR Shareholding |
8th Jul 2022 3:33 pm |
RNS |
Director/PDMR Shareholding |
8th Jul 2022 3:10 pm |
RNS |
Director/PDMR Shareholding |
6th Jul 2022 4:30 pm |
RNS |
Result of General Meeting |
6th Jul 2022 10:11 am |
RNS |
Director/PDMR Shareholding |
5th Jul 2022 12:43 pm |
RNS |
GSK disclose discontinued operations from Q2 2022 |
5th Jul 2022 9:45 am |
RNS |
Director/PDMR Shareholding |
5th Jul 2022 9:30 am |
RNS |
Director/PDMR Shareholding |
1st Jul 2022 3:27 pm |
RNS |
Total Voting Rights |
1st Jul 2022 2:45 pm |
RNS |
GSK completes acquisition of Sierra Oncology |